Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-233.62%Earnings Yield
VS
Market
Sector
Industry
History
$ 1.71Close
$ 0.51 - $ 4.12 52-Week Range
Ticker Information
Ticker
MTNBCompany Name
MATINAS BIOPHARMA HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTMATINAS BIOPHARMA HOLDINGS INC - Earnings Yield Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
MTNB - Earnings Yield Historical data
| Date | Earnings Yield | Market Capitalization | Net Income Common Stock |
|---|---|---|---|
| 6/30/2025 | -233.62% | $ 8.39M | $ -19.61M |
| 3/31/2025 | -512.72% | $ 3.92M | $ -20.08M |
| 12/31/2024 | -821.94% | $ 2.95M | $ -24.25M |
| 9/30/2024 | -585.09% | $ 3.61M | $ -21.13M |
| 6/30/2024 | -58.18% | $ 39.38M | $ -22.91M |
| 3/31/2024 | -52.47% | $ 44.32M | $ -23.25M |
| 12/31/2023 | -36.39% | $ 63.05M | $ -22.94M |
| 9/30/2023 | -35.47% | $ 59.94M | $ -21.26M |
| 6/30/2023 | -28.83% | $ 71.7M | $ -20.67M |
| 3/31/2023 | -14.1% | $ 145.57M | $ -20.53M |
Key Performance Insights, Last 5 Years
- MATINAS BIOPHARMA HOLDINGS INC's latest trailing twelve months (TTM) Earnings Yield stands at -13.34%.
- Over the past 5 years, MATINAS BIOPHARMA HOLDINGS INC's average Earnings Yield has been -126.48%.
- The median Earnings Yield for MATINAS BIOPHARMA HOLDINGS INC during this period was -20.65%
- MATINAS BIOPHARMA HOLDINGS INC reached its highest Earnings Yield over the past 5 years at -10.73%.
- The lowest Earnings Yield recorded by MATINAS BIOPHARMA HOLDINGS INC in the same timeframe -821.94%
Similar metrics to Net Inc. Cmn.:
- Price to Earnings - [Calculation] Measures a company’s [MarketCap] in relation to its Net Income [NetIncCmn]. A high P/E ratio indicates that investors anticipate greater future earnings growth compared to companies with a lower P/E.
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
Definition of Earnings Yield
[Calculation] The Earnings Yield, also known as the inverse of the PE ratio [PE], expresses a company’s earnings [NetIncCmn] as a percentage of [MarketCap].Net Inc. Cmn. / Market Cap
(=) Earnings Yield Earnings Yield for MATINAS BIOPHARMA HOLDINGS INC is calculated as follows: Net Inc. Cmn. [ $ -22.49M ] / Market Cap [ $ 168.55M ]
(=) Earnings Yield [ -13.34% ] MTNB - Earnings Yield, Last 5 years
-821.94%
Minimum
Dec 31, 2024
-10.73%
Maximum
Dec 31, 2020
-126.48%
Average
-20.65%
Median
Earnings Yield Benchmark AnalysisMarket
The chart above depicts the distribution of Earnings Yield for companies in the Total Stock Market. The average Earnings Yield of the companies is 0.34% with a standard deviation of 9.81%.
The following table provides additional summary stats:
Earnings Yield in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | -31.68% |
| max | 32.87% |
| average | 0.34% |
| median | 2.78% |
| std | 9.81% |